A second‐generation <scp>CD38‐CAR‐T</scp> cell for the treatment of multiple myeloma
Hongwen Li(Anhui Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Jiazhuo Wu(Zhengzhou University), Wenting Song(Huazhong Agricultural University), Jing Li(Guangzhou University of Chinese Medicine), Jiwei Li(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Yuyang Gao(Zhengzhou University), Zhuangzhuang Shi(First Affiliated Hospital of Zhengzhou University)
Cited by 7
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
KIR <sup>+</sup> CD8 <sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
|Science|2022|244
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
|Molecular Cancer|2017|176